Jan Johannessen - 12 May 2026 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 May 2026, 16:05:09 UTC
Prior SEC filing
09 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kendra Fox, as Attorney-in-Fact for Jan Johannessen

Key filing fact

Jan Johannessen filed Form 4 for Twist Bioscience Corp (TWST) on 14 May 2026.

Key facts

  • This page summarizes Jan Johannessen's Form 4 filing for Twist Bioscience Corp (TWST).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 May 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 09 Feb 2026.
  • Current net transaction value: -$673,440.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001224168 Primary reporting owner

JOHANNESSEN JAN

Relationship
Director
Address
C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Jan Johannessen
Signature date
14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TWST transaction

Common Stock

Options Exercise

Transaction value
Shares
+12,000
Change %
+68%
Price
$14.00*
Shares after
29,754
Date
12 May 2026
Ownership
Direct
TWST transaction

Common Stock

Sale

Transaction value
$673,440
Shares
-12,000
Change %
-40%
Price
$56.12
Shares after
17,754
Date
12 May 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TWST transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
+12,000
Change %
Price
$0.000000*
Shares after
10,304
Date
12 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,000
Exercise price
$14.00
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .